- Instruments
- Microarrays
- Ultrasound Devices
- NGS Systems
- PCR Instruments
- Other Instruments
- Consumables
- Assay Kits &Reagents
- Disposables
Non-Invasive Prenatal Testing Market Size was valued at USD 3.6 billion in 2022 and is poised to grow at a CAGR of 9.6% from 2023 to 2029. Noninvasive prenatal testing is a new type of genetic testing that is used to screen birth defects and inherited diseases. This test is also known as the cell-free DNA screening. The procedures include both non-invasive techniques and invasive techniques. In non-invasive techniques, serum screening and ultrasonography are included. Whereas, in invasive techniques amniocentesis and chorionic villus sampling are included. Most of the healthcare professionals prefer the non-invasive techniques over invasive, as the invasive techniques have higher risk quotient, also sometimes leads to fetal loss. Noninvasive prenatal testing are the innovative testing procedures that uses cell-free circulating fetal DNA in the maternal serum to screen for more common fetal aneuploidies, such as trisomy 21, trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). Increasing prevalence of these genetic disorders are likely to drive the market for non-invasive prenatal testing over the forecast period. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. The major market participants are adopting the strategies such as mergers and acquisitions to position themselves as strong players.
Non-Invasive Prenatal Testing Market Key Developments:
In February 2018, BD (Becton, Dickinson and Company) announced the commercial availability of the CE-IVD marked PAXgene Blood ccfDNA tube within the European Economic Area and Switzerland (Western Europe).
Non Invasive Prenatal Testing Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
9.8%
Largest Market
North America
Fastest Growing Market
Europe
Noninvasive Prenatal Testing Market Dynamics
The rising awareness among parents, adoption toward IVF procedures is driving the market. In birth outcomes such as birth defects, newborn weight, and multiple births, maternal age plays a major role. The average age at which women are giving first birth has been increasing. As per Centre for Disease Control and Prevention (CDC) report, the mean age of a women at first birth was 25.8 years in 2012, and it has increased to 26 years in 2013, in the U.S. In addition to that, according to the World Health Organization (WHO), about 3,000 to 5,000 children are born with chromosome disorder, approximately 60%-80% of the children with Down syndrome have hearing deficit, and 40%-45% have congenital heart disease. The rise in the prevalence of these genetic disorders is likely to drive the market for non-invasive prenatal testing market.
North America Got Significant Share
Noninvasive Prenatal Testing Market
North America dominates the noninvasive prenatal testing market due to growing adoption of advanced diagnostics in the region and increase in the access to various prenatal testing procedures. North America is expected to hold the largest revenue share over the forecast period. Followed by the North America are the regions of Europe and Asia Pacific. The countries such as India and China are predicted to drive the market in Asia-Pacific region due to favorable population demographics.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Non Invasive Prenatal Testing Market Segmentation
By Product Type
By End User
- Hospitals
- Maternity Clinics
- Diagnostic Centers
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1. Executive Summary |
| 2. Global Non-Invasive Prenatal Testing Market Introduction |
| 2.1. Global Non-Invasive Prenatal Testing Market Taxonomy |
| 2.2. Global Non-Invasive Prenatal Testing Market Definitions |
| 2.2.1. By Product Type |
| 2.2.2. By End User |
| 2.2.3. By Region |
| 3. Global Non-Invasive Prenatal Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Non-Invasive Prenatal Testing Market Dynamic Factors - Impact Analysis |
| 3.6. Global Non-Invasive Prenatal Testing Market – Competition Landscape |
| 4. Global Non-Invasive Prenatal Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Non-Invasive Prenatal Testing Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1. Consumables and Reagents |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Instruments |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global Non-Invasive Prenatal Testing Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1. Public Labs |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Private Labs |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Non-Invasive Prenatal Testing Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia-Pacific |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Middle East and Africa |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Global Non-Invasive Prenatal Testing Market - Opportunity Analysis Index, By Product Type, End User, and Region, 2023 - 2029 |
| 8. North America Non-Invasive Prenatal Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Consumables and Reagents |
| 8.1.2. Instruments |
| 8.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1. Public Labs |
| 8.2.2. Private Labs |
| 8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 8.3.1. USA |
| 8.3.2. Canada |
| 8.4. North America Non-Invasive Prenatal Testing Market - Opportunity Analysis Index, By Product Type, End User, and Country, 2023 - 2029 |
| 8.5. North America Non-Invasive Prenatal Testing Market Dynamics – Trends |
| 9. Europe Non-Invasive Prenatal Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Consumables and Reagents |
| 9.1.2. Instruments |
| 9.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Public Labs |
| 9.2.2. Private Labs |
| 9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Germany |
| 9.3.2. UK |
| 9.3.3. France |
| 9.3.4. Spain |
| 9.3.5. Italy |
| 9.3.6. Rest of Europe |
| 9.4. Europe Non-Invasive Prenatal Testing Market - Opportunity Analysis Index, By Product Type, End User, and Country, 2023 - 2029 |
| 9.5. Europe Non-Invasive Prenatal Testing Market Dynamics – Trends |
| 10. Asia-Pacific Non-Invasive Prenatal Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Consumables and Reagents |
| 10.1.2. Instruments |
| 10.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Public Labs |
| 10.2.2. Private Labs |
| 10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. China |
| 10.3.2. India |
| 10.3.3. Japan |
| 10.3.4. ASEAN |
| 10.3.5. Australia & New Zealand |
| 10.3.6. Rest of Asia-Pacific |
| 10.4. Asia-Pacific Non-Invasive Prenatal Testing Market - Opportunity Analysis Index, By Product Type, End User, and Country, 2023 - 2029 |
| 10.5. Asia-Pacific Non-Invasive Prenatal Testing Market Dynamics – Trends |
| 11. Latin America Non-Invasive Prenatal Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 11.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Consumables and Reagents |
| 11.1.2. Instruments |
| 11.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Public Labs |
| 11.2.2. Private Labs |
| 11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Brazil |
| 11.3.2. Mexico |
| 11.3.3. Argentina |
| 11.3.4. Rest of Latin America |
| 11.4. Latin America Non-Invasive Prenatal Testing Market - Opportunity Analysis Index, By Product Type, End User, and Country, 2023 - 2029 |
| 11.5. Latin America Non-Invasive Prenatal Testing Market Dynamics – Trends |
| 12. Middle East and Africa Non-Invasive Prenatal Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 12.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Consumables and Reagents |
| 12.1.2. Instruments |
| 12.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Public Labs |
| 12.2.2. Private Labs |
| 12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Gulf Cooperation Council (GCC) Countries |
| 12.3.2. Israel |
| 12.3.3. South Africa |
| 12.3.4. Rest of MEA |
| 12.4. MEA Non-Invasive Prenatal Testing Market - Opportunity Analysis Index, By Product Type, End User, and Country, 2023 - 2029 |
| 12.5. MEA Non-Invasive Prenatal Testing Market Dynamics – Trends |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, Product Type Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. F. Hoffmann-La Roche Ltd. |
| 13.2.2. PerkinElmer Inc. |
| 13.2.3. Natera, Inc. |
| 13.2.4. BGI |
| 13.2.5. Laboratory Corp. of America Holdings |
| 13.2.6. Agilent Technologies |
| 13.2.7. Centogene N.V. |
| 13.2.8. Illumina, Inc. |
| 13.2.9. Qiagen N.V. |
| 13.2.10. Quest Diagnostics |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
- PerkinElmer, Inc. (U.S.)
- QIAGEN N.V. (Germany)
- Becton, Dickinson and Company (U.S)
- Agilent Technologies, Inc. (U.S.)
- Beijing Genomics Institute (China)
- GE Healthcare (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Illumina, Inc. (U.S.)
- Thermo Fisher Scientific, Inc. (U.S.)
- Hoffmann-La Roche Ltd. (Switzerland)
- Pacific Biosciences of California, Inc. (U.S.)